Evolus to Participate in November Investor Conferences
Evolus, Inc. (NASDAQ: EOLS) will present at the Stifel 2023 Healthcare Conference on November 15, 2023, and at the 6th Annual Evercore ISI HealthCONx Conference on November 28, 2023. Audio webcasts of the events will be available on Evolus' website, with replays available for 90 days.
11/01/2023 - 08:45 AM
NEWPORT BEACH, Calif. --(BUSINESS WIRE)--
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that members of its management team will present at the following investment conferences in November.
Event:
Stifel 2023 Healthcare Conference
Date:
Wednesday, November 15, 2023
Time:
11:30 AM ET
Event:
6th Annual Evercore ISI HealthCONx Conference
Date:
Tuesday, November 28, 2023
Time:
9:35 AM ET
Audio webcasts of these events will be available on the investor relations section of Evolus’ website at www.evolus.com . Replays of the webcasts will be available for 90 days after the date of each presentation.
About Evolus, Inc.
Evolus (Nasdaq: EOLS) is a performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau® (prabotulinumtoxinA-xvfs), globally licensed under the brand name Nuceiva® . The product is manufactured in a state-of-the-art facility using Hi-Pure™ technology. Evolus is expanding its product portfolio having entered into a definitive agreement to be the exclusive U.S. distributor of Evolysse™, a line of five unique dermal fillers currently in late-stage development. Visit us at www.evolus.com , and follow us on LinkedIn , X , Instagram or Facebook .
Jeuveau® and Nuceiva® are registered trademarks of Evolus, Inc.
Evolysse™ is a trademark of Evolus, Inc.
Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231031666324/en/
Investor Contacts:
Ned Mitchell
Arbor Advisory Group
Email: ir@evolus.com
Media Contact:
Email: media@evolus.com
Source: Evolus
When will Evolus present at the Stifel 2023 Healthcare Conference?
Evolus will present at the Stifel 2023 Healthcare Conference on November 15, 2023.
When will Evolus present at the 6th Annual Evercore ISI HealthCONx Conference?
Evolus will present at the 6th Annual Evercore ISI HealthCONx Conference on November 28, 2023.
Where can I find the audio webcasts of the events?
The audio webcasts of the events will be available on Evolus' website at www.evolus.com.
How long will the replays of the webcasts be available?
The replays of the webcasts will be available for 90 days after the date of each presentation.
EOLS Rankings
#2678 Ranked by Stock Gains
EOLS Stock Data
Industry
Medicinal and Botanical Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major, Manufacturing, Medicinal and Botanical Manufacturing
Country
US
City
Newport Beach
About EOLS
evolus, inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the united states. it offers jeuveau, a proprietary 900 kilodalton purified botulinum toxin type a formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. the company was founded in 2012 and is headquartered in newport beach, california.